Panda, Arunima
Ragunath, Krish
Pajic, Marina https://orcid.org/0000-0002-3871-3829
Greening, David W.
Falasca, Marco https://orcid.org/0000-0002-9801-7235
Article History
Received: 9 January 2025
Revised: 12 March 2025
Accepted: 2 April 2025
First Online: 7 May 2025
Competing interests
: MF is a member of LIPOVEXA S.r.l., a spin-off company focused on developing innovative treatments for diabetes, obesity and liver health. No additional relationships or activities are reported that could have influenced the findings of this work. DWG is an industry partner with Thermo Fisher Scientific and senior editor for Proteomics (Systems Biology) and the Journal of Extracellular Vesicles. His association with these journals did not impact the editorial review or the decision to publish this article. The remaining authors declare no competing interests.
: All participants provided informed consent, and the study was approved by the Research and Ethics committees of Royal Perth Hospital (RGS0000004208) and the Curtin University Human Research Ethics Committee (approval number HRE2021-0757).